This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Kinyuseisaku: Política Monetaria en Japón (C)
Alfaro, Laura; White, HilaryCase HBS-714S12EconomicsAsumió el cargo en diciembre de 2012, el primer ministro, Shinzo Abe, se determinó para reactivar economía estancada de Japón a través de un ambicioso plan conocido como 'Abenomics.' Bajo la dirección del nuevo gobernador del banco central, Haruhiko Kuroda, el Banco de Japón adoptó la flexibilización cuantitativa como su nueva política monetaria, comprometiéndose a duplicar la base monetaria de la nación en dos años a través de la compra de bonos...Starting at €5.74
-
Kinyuseisaku: Monetary Policy in Japan (C)
Alfaro, Laura; White, HilaryCase HBS-713086-EEconomicsAssuming office in December 2012, Prime Minister Shinzo Abe was determined to revive Japan's stagnating economy through an ambitious plan known as 'Abenomics.' Under the guidance of the newly appointed governor of the central bank, Haruhiko Kuroda, the Bank of Japan adopted quantitative easing as its new monetary policy, pledging to double the nation's monetary base in two years through the purchase of long-term government bonds. While Kuroda ins...Starting at €5.74
-
Land Acquisition in India: Public Purpose and Private Property (C)
Alfaro, Laura; Iyer, Lakshmi; Tahilyani, RachnaCase HBS-714023-EEconomicsStarting at €5.74
-
China: Flotar o no flotar (C) Esquel Group y el Renminbi chino
Alfaro, Laura; Di Tella, Rafael; Vogel, IngridCase HBS-707S10EconomicsEn julio de 2005, China revaluó su moneda en un 2,1% y ajustar su régimen de tipo de cambio hacia un sistema más basado en el mercado. Esquel Group, una gestión familiar, textiles privadas firma especializada en camisas de algodón de alta calidad con su mayoría de base de producción se encuentra en China, estaba entre aquellas empresas que se enfrentan con el reto de hacer frente a la revaluación del yuan y la posibilidad de apreciación futura . ...Starting at €5.74
-
dcs plus: Romanian SaaS Firm Goes International - Teaching Note
Phillip C. NellTeaching Note IVEY-8B20M173-EStrategyTeaching Note for product 9B20M173.Starting at €0.00
-
dcs plus: Romanian SaaS Firm Goes International
Phillip C. NellCase IVEY-9B20M173-EEntrepreneurship, StrategyOn a cold Monday morning in January 2018, the founder and chief executive officer of dcs plus was sitting in a taxi on his way to catch a plane to Dubai, United Arab Emirates. In Dubai, he would be visiting the Middle East subsidiary of his company, a RomStarting at €8.20
-
Pfizer and the Challenges of the Pharmaceutical Industry (A)
Renate Kratochvil; Phillip C. NellCase IVEY-9B19M076-EStrategyIn 2018, President of the United States, Donald Trump, criticized the company Pfizer Inc. (Pfizer) for increasing drug prices—which had been a strategic move by Pfizer in response to industry-wide challenges. This announcement highlighted the complex dynaStarting at €8.20
-
Pfizer and the Challenges of the Pharmaceutical Industry (A) - Teaching Note
Renate Kratochvil; Phillip C. NellTeaching Note IVEY-8B19M076-EStrategyTeaching note for product 9B19M076.Starting at €0.00
-
Pfizer and the Challenges of the Pharmaceutical Industry (B) - Teaching Note
Renate Kratochvil; Phillip C. NellTeaching Note IVEY-8B19M077-EStrategyTeaching Note to accompany product 9B19M077.Starting at €0.00
-
Pfizer and the Challenges of the Pharmaceutical Industry (B)
Renate Kratochvil; Phillip C. NellCase IVEY-9B19M077-EStrategyCase B complements Case A, describing pharmaceutical companies’ strategic responses—such as mega-mergers and acquisitions and specialization—to industry-wide global challenges and highlights strategic decisions by Pfizer’s chief executive officers betweenStarting at €5.74